Variant report
Variant | esv19521 |
---|---|
Chromosome Location | chr3:88664755-88665910 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs577134626 | chr3:88664765-88664766 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs181050730 | chr3:88664784-88664785 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs545813867 | chr3:88664785-88664786 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs75028603 | chr3:88664830-88664831 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs549930995 | chr3:88664839-88664840 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs77809377 | chr3:88664850-88664851 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs185360646 | chr3:88664851-88664852 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs190849305 | chr3:88664857-88664858 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs567048845 | chr3:88664870-88664871 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs537684422 | chr3:88664900-88664901 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs558511250 | chr3:88664923-88664924 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs112339119 | chr3:88664935-88664936 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs552976163 | chr3:88664955-88664956 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs117602038 | chr3:88665041-88665042 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs147511365 | chr3:88665070-88665071 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs13090780 | chr3:88665081-88665082 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs183470988 | chr3:88665136-88665137 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs185963886 | chr3:88665169-88665170 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs571774000 | chr3:88665181-88665182 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs192022907 | chr3:88665196-88665197 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs182880587 | chr3:88665235-88665236 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs6776805 | chr3:88665293-88665294 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs563497091 | chr3:88665304-88665305 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs531012285 | chr3:88665326-88665327 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs188451889 | chr3:88665335-88665336 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs112230762 | chr3:88665337-88665338 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs74560495 | chr3:88665349-88665350 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs548484605 | chr3:88665380-88665381 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs560347125 | chr3:88665404-88665405 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs527954677 | chr3:88665418-88665419 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs62269530 | chr3:88665419-88665420 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs148575507 | chr3:88665424-88665425 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs113127410 | chr3:88665450-88665451 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs6777020 | chr3:88665467-88665468 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs151123977 | chr3:88665570-88665571 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs59780992 | chr3:88665629-88665630 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs11718555 | chr3:88665666-88665667 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs192276665 | chr3:88665752-88665753 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs62269531 | chr3:88665764-88665765 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs71628821 | chr3:88665810-88665811 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs114930133 | chr3:88665820-88665821 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs372371212 | chr3:88665857-88665858 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs113176386 | chr3:88665871-88665872 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs139683751 | chr3:88665872-88665873 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs558100758 | chr3:88665894-88665895 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs143605180 | chr3:88665896-88665897 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs543047382 | chr3:88665898-88665899 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Cervical cancer | 21062161 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Breast cancer | 22032731 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Wilms tumour | 21544195 | CNVD |
Soft tissue tumor | 16732325 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
craniofacial dysmorphism | 21918468 | CNVD |
Cancer | 20164920 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Lung cancer | 19547694 | CNVD |
Cancer | 20164919 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:88664600-88667800 | Enhancers | Fetal Brain Female | brain |
2 | chr3:88665000-88666000 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
3 | chr3:88665000-88666600 | Enhancers | Fetal Brain Male | brain |
4 | chr3:88665400-88667600 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
5 | chr3:88665600-88666000 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
6 | chr3:88665600-88666200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
7 | chr3:88665600-88666200 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
8 | chr3:88665600-88666400 | Enhancers | Cortex derived primary cultured neurospheres | brain |
9 | chr3:88665600-88666400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
10 | chr3:88665800-88666000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
11 | chr3:88665800-88666200 | Enhancers | Brain Germinal Matrix | brain |